Open AccessRisk factors for SARS-CoV-2 seroprevalence following the first pandemic wave in UK healthcare workers in a large NHS Foundation Trust
Author(s) -
Hayley Colton,
David Hodgson,
Hailey Hornsby,
Rebecca L. Brown,
Joanne Mckenzie,
Kirsty L Bradley,
Cameron James,
Benjamin B. Lindsey,
Sarah Birch,
Louise Marsh,
Steven Wood,
Martin Bayley,
Gary W. Dickson,
David C. James,
Martin J.H. Nicklin,
Jon R. Sayers,
Domen Zafred,
Sarah RowlandJones,
Goura Kudesia,
Adam J. Kucharski,
Thomas C. Darton,
Thushan I. de Silva,
Paul Collini
Publication year - 2021
Publication title -
wellcome open research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.298
H-Index - 21
ISSN - 2398-502X
DOI - 10.12688/wellcomeopenres.17143.1
Subject(s) - seroprevalence , pandemic , covid-19 , foundation (evidence) , health care , medicine , virology , political science , outbreak , disease , infectious disease (medical specialty) , law , antibody , immunology , serology
Background: We aimed to measure SARS-CoV-2 seroprevalence in a cohort of healthcare workers (HCWs) during the first UK wave of the COVID-19 pandemic, explore risk factors associated with infection, and investigate the impact of antibody titres on assay sensitivity. Methods: HCWs at Sheffield Teaching Hospitals NHS Foundation Trust were prospectively enrolled and sampled at two time points. SARS-CoV-2 antibodies were tested using an in-house assay for IgG and IgA reactivity against Spike and Nucleoprotein (sensitivity 99·47%, specificity 99·56%). Data were analysed using three statistical models: a seroprevalence model, an antibody kinetics model, and a heterogeneous sensitivity model. Results: As of 12th June 2020, 24·4% (n=311/1275) of HCWs were seropositive. Of these, 39·2% (n=122/311) were asymptomatic. The highest adjusted seroprevalence was measured in HCWs on the Acute Medical Unit (41·1%, 95% CrI 30·0–52·9) and in Physiotherapists and Occupational Therapists (39·2%, 95% CrI 24·4–56·5). Older age groups showed overall higher median antibody titres. Further modelling suggests that, for a serological assay with an overall sensitivity of 80%, antibody titres may be markedly affected by differences in age, with sensitivity estimates of 89% in those over 60 years but 61% in those ≤30 years. Conclusions: HCWs in acute medical units working closely with COVID-19 patients were at highest risk of infection, though whether these are infections acquired from patients or other staff is unknown. Current serological assays may underestimate seroprevalence in younger age groups if validated using sera from older and/or more symptomatic individuals.